CAI · earnings call history
Caris Life Sciences Q2 FY26 — Record Clinical Volume and Strong Financials Drive Raised Outlook
Read the briefCaris Life Sciences Q1 FY26 — Strong Revenue Growth and Profitability Driven by Molecular Profiling
Read the briefCaris Life Sciences Q4 FY25 — Record Revenue, Strong Profitability, and Early Detection Progress
Read the briefBrowse all US companies on the earnings-call register.